Topics in Breast and Gynecologic Cancers
Saturday, October 20, 2012
7:30 am – 12:15 pm
Dana-Farber Cancer Institute
Yawkey Center for Cancer Care
450 Brookline Avenue
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education
Quicklinks
Course Objectives | Agenda | Faculty
Registration Information | Credits | Directions & Parking
Course Overview
A major challenge to the successful management of breast and gynecologic cancers is the timeliness of diagnosis. Lack of knowledge about early symptoms can lead to delayed diagnoses and poor clinical outcomes. This half-day course, designed for medical, radiation and surgical oncologists, primary care physicians, gynecologists, nurse practitioners, and other interested clinicians, will enhance practitioners' knowledge in identifying and managing early breast and gynecologic malignancies. Through lecture and Q&A, participants will consider appropriate clinical work-ups for several cancerous/pre-cancerous breast and gynecologic conditions and examine the appropriate use of MRI for breast cancer screening and management. In addition, faculty will share updates on treatment advances in ovarian cancer and hormone responsive breast cancer.
Learning Objectives
At the conclusion of this course, attendees will be able to: identify women who are at higher risk for developing ovarian cancer; conduct a clinical work-up of DCIS; determine which patients require a referral for breast MRI; clarify the significance of vaginal bleeding, including its potential role in gynecologic cancer, in postmenopausal women; describe treatment options for hormone responsive cancers that include consideration of menopausal status; and utilize surgical, medical and/or radiation treatment options for early stage ER+ breast cancer.
ACGME COMPETENCIES: This course is designed to enhance one or more of the following Accreditation Council of Graduate Medical Education competencies: Patient Care, Medical Knowledge, and Practice-based Learning and Improvement.
About the Susan F. Smith Center for Women's Cancers at Dana-Farber/ Brigham and Women's Cancer Center
The Susan F. Smith Center for Women's Cancers brings together a team of renowned experts in breast and gynecologic cancers to provide women with the most promising cancer treatments available. With an equal commitment to clinical research and care, the faculty is able to facilitate the rapid conversion of scientific discoveries into lifesaving treatments.
In addition to offering the latest treatments, the Center also provides a wide range of specialized treatment programs and other services – from support groups to complementary therapies – to help meet the diverse needs of women facing cancer.
Agenda
7:30 am
Registration and Continental Breakfast
SESSION 1: Management of Early Breast and Gynecologic Malignancies
Moderator: Ursula A. Matulonis, MD
8:00 am
Welcome and First Session Introduction
8:15 am
Ovarian Cancer Risk Assessment
Daniel W. Cramer, MD, ScD
8:35 am
Questions and Answers
8:40 am
Work-up and Local Management of Ductal Carcinoma in Situ
Susan L. Troyan, MD
9:00 am
Questions and Answers
9:05 am
Appropriate Use of MRI for Breast Screening and Management
Mehra Golshan, MD, FACS
9:25 am
Questions and Answers
9:30 am
Work-up of Vaginal Bleeding in Post Menopausal Women
Colleen M. Feltmate, MD
9:50 am
Questions and Answers
9:55 am
First Session Review
10:05 am
Break
SESSION II: Treatment Updates in Breast and Gynecologic Cancers
Moderator: J. Dirk Iglehart, MD
10:20 am
Second Session Introduction
10:30 am
PARP Inhibitors for Ovarian Cancer
Susana M. Campos, MD, MPH
10:50 am
Questions and Answers
10:55 am
Hormone Responsive Breast Cancer: Treatment Options for Pre- and Post-Menopausal Women
Erica L. Mayer, MD, MPH
11:15 am
Questions and Answers
11:20 am
Treatment of Early ER+ Breast Cancer: Case Panel Discussion
- Surgical Management – Susan L. Troyan, MD
- Medical Management – Ian E. Krop, MD, PhD
- Radiation Management – Julia S. Wong, MD
11:50 am
Questions and Answers
12:05 pm
Second Session Review
12:15 pm
Concluding Remarks
Faculty
J. Dirk Iglehart, MD, Course Co-Director
Director, Susan F. Smith Center for Women's Cancers
Dana-Farber/Brigham and Women's Cancer Center;
Anne E. Dyson Professor in Women's Cancer and Surgery
Harvard Medical School
Ursula A. Matulonis, MD, Course Co-Director
Medical Director, Gynecologic Oncology, Susan F. Smith Center for Women's Cancers
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine
Harvard Medical School
Susana M. Campos, MD, MPH
Medical Oncologist, Gynecologic Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Daniel W. Cramer, MD, ScD
Director, OB/GYN Epidemiology Center; Surgical Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Colleen M. Feltmate, MD
Director, Minimally Invasive Surgery in Gynecologic Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Mehra Golshan, MD, FACS
Director, Breast Surgical Services
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Surgery
Harvard Medical School
Ian E. Krop, MD, PhD
Medical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Erica L. Mayer, MD, MPH
Medical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Susan L. Troyan, MD
Surgical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Surgery
Harvard Medical School
Julia S. Wong, MD
Radiation Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Radiation Oncology
Harvard Medical School
HMS Disclosure Policy
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
The Harvard Medical School designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $50.00 (non-refundable).
Registration fee includes continental breakfast, course materials, and complimentary parking.
To register by mail: Send a completed registration form and check payable to DF/BWCC to:
Susan F. Smith Center for Women's Cancers CME
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215
The registration form must be postmarked no later than October 5, 2012.
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.
Directions and Parking
This conference will take place on the 3rd Floor of Dana-Farber's Yawkey Center for Cancer Care, 450 Brookline Avenue, Boston, MA. Complimentary parking is available in the Dana-Farber garage located at 1 Jimmy Fund Way. For directions, visit: www.dana-farber.org/directions.
